image
Myriad Genetics, Inc. MYGN
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
Watchlist
$ 7.53
-3.14 %
$ 688 M
Market Cap
-5.25
P/E
Price Target Average
242.33%
Revenue Forecast Estimate
9.26%
EBIT Estimate
6.50%
Net Income Estimate
22.37%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Myriad Genetics, Inc.
image
Wall Street analysts predict an average 1-year price target for MYGN of $25.8 , with forecasts ranging from a low of $11.5 to a high of $35 .
MYGN Lowest Price Target Wall Street Target
11.5 USD 52.72%
MYGN Average Price Target Wall Street Target
25.8 USD 242.33%
MYGN Highest Price Target Wall Street Target
35 USD 364.81%
Price
Max Price Target
Min Price Target
Average Price Target
35353030252520201515101055Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart MYGN

image
$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart MYGN

image
$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)($1.4b)($1.4b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart MYGN

image
$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029